COAXIL

This brand name is authorized in Croatia, Estonia, Lithuania, Poland, Romania.

Active ingredients

The drug COAXIL contains one active pharmaceutical ingredient (API):

1
UNII YG0E19592I - TIANEPTINE SODIUM
 

Tianeptine is an antidepressant. In man, tianeptine is characterised by marked action on somatic complaints, especially gastrointestinal complaints related to anxiety and mood disturbances. Moreover, tianeptine has no effect on sleep and alertness nor on the cholinergic system (no anticholinergic symptoms).
 
Read more about Tianeptine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N06AX14 Tianeptine N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1019360, 1784459, 1832565
HR Agencija za lijekove i medicinske proizvode HR-H-233409906
LT Valstybinė vaistų kontrolės tarnyba 1003704, 1005045, 1081945, 1082039
PL Rejestru Produktów Leczniczych 100015168, 100366488, 100367252, 100375719
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W41558001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈